Article

Daily Medication Pearl: Aggrenox (Aspirin/ER, Dipyridamole)

Aggrenox is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Medication Pearl of the Day: Aggrenox (Aspirin/ER, Dipyridamole)

Indication: Aggrenox is a combination antiplatelet agent indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Aggrenox reduces the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

Aggrenox

Insight:

  • Dosing: One capsule twice daily (morning and evening) with or without food.
  • Dosage forms: Capsule 25 mg aspirin/200 mg extended-release dipyridamole.
  • Adverse events (AEs): The most frequently reported AEs (>10% and greater than placebo) were headache, dyspepsia, abdominal pain, nausea, and diarrhea.
  • Mechanism of action: The antithrombotic action of Aggrenox is the result of the additive antiplatelet effects of dipyridamole and aspirin.
  • Manufacturer: Boehringer Ingelheim

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com